Oslo, 27.08.2026 — Hynion AS (the “Company”) has received a letter dated 26 August 2026 from Euronext Oslo Børs stating that the exchange will consider whether the Company’s shares should be delisted. The exchange refers to the outstanding 2025 annual report, previous delays in the Company’s financial reporting, outstanding invoices to Euronext, and its view that the Company does not currently have an ongoing business suitable for listing.Pursuant to Euronext Growth Oslo Rule Book Part II section 3.18 (4), the Company has been invited to explain what measures may be taken for the Company to again become suitable for listing, and has been given a deadline of 9 September 2026 to respond.
The Company will respond within the deadline.
The Company’s shares remain suspended from trading in accordance with the Company.
This information is subject to the disclosure requirements pursuant to the EU Market Abuse Regulation and is published in accordance with the rules of Euronext Growth Oslo